Fresh from the Novartis/Trump scandal, ex-CEO Joe Jimenez jumps on the board of uBiome — a biotech launching an R&D group
After figuring in as one of the central figures for one of the most talked about scandals in biopharma history, ex-Novartis CEO Joe Jimenez is stepping back out onto the stage today with a board seat at a commercial microbiome company that is now setting its sights on creating a drug development arm.
Launched 6 years ago from its base in the Bay Area, uBiome has launched a pair of consumer tests that can do at-home tests on your gut or the STDs that women face, like chlamydia and gonorrhea. Now the company has raised $83 million from venture backers — led by OS Fund — in a new drive to join the pack developing new microbiome therapies. That’s been a fast-growing field in recent times.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters